Long-term follow-up results of ruxolitinib as salvage therapy for chronic graft-versus-host disease

Introduction: Chronic graft-versus-host disease poses a significant challenge after allogeneic hematopoietic stem cell transplantation with initial treatment often relying on high-dose steroids. However, managing steroid-refractory disease remains daunting. Recent insights into the mechanisms have u...

Full description

Saved in:
Bibliographic Details
Main Authors: Neslihan Mandaci Sanli, Esen Karakuş
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137925001038
Tags: Add Tag
No Tags, Be the first to tag this record!